4//SEC Filing
JAEGER RAVEN 4
Accession 0001437749-22-021414
CIK 0001053691other
Filed
Aug 25, 8:00 PM ET
Accepted
Aug 26, 6:08 PM ET
Size
5.4 KB
Accession
0001437749-22-021414
Insider Transaction Report
Form 4
JAEGER RAVEN
Chief Regulatory Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-06-07+8,000→ 8,000 totalExercise: $7.75Exp: 2032-06-07→ Common Stock (8,000 underlying)
Footnotes (1)
- [F1]The shares underlying the options will vest in 36 equal (or as nearly equal as possible) monthly installments on the last calendar day of each month over a 36-month period beginning June 30, 2022.
Documents
Issuer
Diffusion Pharmaceuticals Inc.
CIK 0001053691
Entity typeother
Related Parties
1- filerCIK 0001944263
Filing Metadata
- Form type
- 4
- Filed
- Aug 25, 8:00 PM ET
- Accepted
- Aug 26, 6:08 PM ET
- Size
- 5.4 KB